European IP

LNPs: Small lipids, big potential in nucleic acid delivery

LNPs: Small lipids, big potential in nucleic acid delivery

Lipid nanoparticles (LNPs) have emerged as a leading pharmaceutical formulation technology, particularly for nucleic acid delivery.

Kilburn & Strode announce this year’s Partner and Counsel promotions

News

Kilburn & Strode announce this year’s Partner and Counsel promotions

These promotions continue our commitment to advancing our people, investing in everyone's development, whilst looking to our future.

Prior use ''pitfalls'' – three key tips for success in EPO oppositions

Technical Tips

Prior use ''pitfalls'' – three key tips for success in EPO oppositions

This practical update takes a look at how best to use public prior use in an EPO opposition and the potential pitfalls to avoid.

At the interface: patenting MedTech software at the EPO

Case law

At the interface: patenting MedTech software at the EPO

Medical device software and user interfaces are becoming an increasingly important differentiator for medtech companies. New GUIs and data visualisation tools – for clinicians or for patients – may m...

Majorana Qubits: Ripe for the Patenting?

Thoughts

Majorana Qubits: Ripe for the Patenting?

Quantum computing has taken the technological world by storm, with public attention exploding over the past decade. The revolution of fault-tolerant quantum computers on the horizon offers to vastly c...

Lookalike Legal Battle: Thatchers Takes on Aldi Over Copycat Cider

Case law

Lookalike Legal Battle: Thatchers Takes on Aldi Over Copycat Cider

Trade mark registration and enforcement is an important tool for brand owners. Once registered, a trade mark allows the owner to prevent third parties from using the same or a confusingly similar mark...

World’s first CRISPR-based therapy to be offered on the NHS in England

CRISPR

World’s first CRISPR-based therapy to be offered on the NHS in England

The role of National Institute for Heath and Care Excellence (NICE) is to provide an independent evaluation of how treatments affect health outcomes and whether they are cost-effective for the public ...

A cautionary tale for medical use claims in Europe

News

A cautionary tale for medical use claims in Europe

A recent, first-instance decision from an Opposition Division (OD) suggests that the European Patent Office (EPO) could tighten their assessment of medical use claims under Article 123(2) EPC (the req...

A bend in the road for electric vehicles: what we can learn from battery patent filings (Part 2 – Electrode materials)

Thoughts

A bend in the road for electric vehicles: what we can learn from battery patent filings (Part 2 – Electrode materials)

Part 1 of this mini-series looked at patent filing trends for different core battery chemistries and solid electrolytes and speculated whether they provide insight into the progress of the battery ind...